Joint Heidelberg-IDC Translational Diabetes Program

The Joint Heidelberg-IDC Translational Diabetes Unit represents the translational and clinical arm of the IDC Diabetes activities and has been established in collaboration with the University Hospital Heidelberg, Germany, and the Collaborative Research Center 1118, funded by the Deutsche Forschungsgemeinschaft DFG.

This unit is co-directed by Peter Nawroth, Clinical director of the Inner Medicine I department at Heidelberg University Hospital, and IDC director Stephan Herzig and offers the opportunity to directly transfer findings from the IDC research divisions into clinical practice.

A particular focus is placed on therapies geared towards the remission of diabetes long-term complications and combinatorial therapies against conditions of chronic malnutrition, supported by both patient-derived biobanks and clinical trials.